Credit Agricole’s GSK GSK Stock Holding History

Credit Agricole’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.3M	Sell	114,180 -14,297	-11%	-$775K	0.02%	516
2025 Q4	$6.3M	Buy	+128,477	New	+$5.99M	0.01%	535
2025 Q1	$232K	Hold	6,000	–	–	﹤0.01%	1089
2024 Q4	$203K	Buy	6,000 +2,000	+50%	+$72K	﹤0.01%	1120
2024 Q3	$164K	Hold	4,000	–	–	﹤0.01%	1087
2024 Q2	$154K	Sell	4,000 -6,000	-60%	-$252K	﹤0.01%	945
2024 Q1	$393K	Hold	10,000	–	–	﹤0.01%	695
2023 Q4	$371K	Buy	10,000 +2,800	+39%	+$101K	﹤0.01%	625
2023 Q3	$261K	Sell	7,200 -2,800	-28%	-$99.4K	﹤0.01%	524
2023 Q2	$356K	Hold	10,000	–	–	0.01%	383
2023 Q1	$356K	Hold	10,000	–	–	0.01%	354
2022 Q4	$351K	Buy	10,000 +2,800	+39%	+$93.3K	0.01%	374
2022 Q3	$212K	Hold	7,200	–	–	﹤0.01%	397
2022 Q2	$392K	Hold	7,200	–	–	0.01%	356
2022 Q1	$392K	Hold	7,200	–	–	0.01%	367
2021 Q4	$397K	Hold	7,200	–	–	0.01%	364
2021 Q3	$344K	Hold	7,200	–	–	0.01%	343
2021 Q2	$358K	Hold	7,200	–	–	0.01%	310
2021 Q1	$321K	Buy	7,200 +2,084	+41%	+$94.6K	0.01%	296
2020 Q4	$235K	Buy	5,116 +3,600	+237%	+$165K	0.01%	312
2020 Q3	$71K	Buy	1,516 +400	+36%	+$20K	﹤0.01%	343
2020 Q2	$57K	Hold	1,116	–	–	﹤0.01%	318
2020 Q1	$53K	Buy	1,116 +800	+253%	+$42.7K	﹤0.01%	315
2019 Q4	$19K	Hold	316	–	–	﹤0.01%	363
2019 Q3	$17K	Hold	316	–	–	﹤0.01%	431
2019 Q2	$16K	Buy	+316	New	+$15.9K	﹤0.01%	426
2015 Q3	–	Sell	-4,687	Closed	-$244K	–	1464
2015 Q2	$244K	Buy	4,687 +1,250	+36%	+$70.4K	﹤0.01%	1254
2015 Q1	$198K	Sell	3,437 -7,779	-69%	-$446K	﹤0.01%	1339
2014 Q4	$590K	Buy	+11,216	New	+$627K	﹤0.01%	1222

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Credit Agricole's GSK Position: Q1 2026 in Review

Credit Agricole reduced its GSK (GSK) stake by 11% in Q1 2026, selling an estimated $775K and leaving 114,180 shares worth $6.3M. The position accounts for 0.02% of the portfolio, ranked #516.

Credit Agricole first reported a position in GSK in Q4 2014 and has held it in 29 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Credit Agricole held 114,180 shares of GSK worth $6.3M as of Q1 2026.
Credit Agricole sold 14,297 GSK shares in Q1 2026, an estimated $775K.
GSK made up 0.02% of Credit Agricole's portfolio in Q1 2026, its #516 holding.
Credit Agricole first reported a position in GSK in Q4 2014 and has held it in 29 quarters since.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Credit Agricole's 13F filing for Q1 2026, filed 15 May 2026.